Navigantis is a Miami, FL–based company developing an interventional robotic platform for a wide range of neurovascular procedures and indications, including Acute Ischemic Stroke. The platform targets neurovascular care with robotics to address emergent and other cerebrovascular conditions. Led by CEO Mor Dayan, the company is focused on advancing development and expanding operational capabilities. Navigantis recently closed a $12M Series A to support those plans. Management says the funds will be used to expand operations and accelerate product development. No operating metrics were disclosed in the article.

Total raised

$12M

Funding rounds

1

Latest round

Series A

Latest activity

Jul 2024